Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Ferrante

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Mabs|May 7, 2020
<i>Post-hoc</i> assessment of the immunogenicity of three antibodies reveals distinct immune stimulatory mechanismsRobin E Walsh, Megan Lannan, Yi Wen, et al.
The AAPS Journal|March 19, 2026
Correction: Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin MoleculesNichole A Reynolds, Yan Q Chen, Richard E Higgs, et al.
The AAPS Journal|October 14, 2025
Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin MoleculesNichole A Reynolds, Yan Q Chen, Richard E Higgs, et al.
British Journal of Pharmacology|February 13, 2023
Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failurePetra Verdino, Stacey L Lee, Fariba N Cooper, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 19, 2019
A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic ProteinsAndrzej M Kierzek, Timothy P Hickling, Isabel Figueroa, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Mabs|May 7, 2020
<i>Post-hoc</i> assessment of the immunogenicity of three antibodies reveals distinct immune stimulatory mechanismsRobin E Walsh, Megan Lannan, Yi Wen, et al.
The AAPS Journal|March 19, 2026
Correction: Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin MoleculesNichole A Reynolds, Yan Q Chen, Richard E Higgs, et al.
The AAPS Journal|October 14, 2025
Affinity Capture Elution Coupled with Cell-based Cyclic Adenosine Monophosphate Assay as a Platform Method for Detection of Neutralizing Antibodies to Incretin MoleculesNichole A Reynolds, Yan Q Chen, Richard E Higgs, et al.
British Journal of Pharmacology|February 13, 2023
Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failurePetra Verdino, Stacey L Lee, Fariba N Cooper, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 19, 2019
A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic ProteinsAndrzej M Kierzek, Timothy P Hickling, Isabel Figueroa, et al.
Pageof 3